Works matching IS 03656233 AND DT 2022 AND VI 355 AND IP 5


Results: 14
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    Novel substituted 5‐methyl‐4‐acylaminoisoxazoles as antimitotic agents: Evaluation of selectivity to LNCaP cancer cells.

    Published in:
    Archiv der Pharmazie, 2022, v. 355, n. 5, p. 1, doi. 10.1002/ardp.202100425
    By:
    • Sadovnikov, Kirill S.;
    • Vasilenko, Dmitry A.;
    • Gracheva, Yulia A.;
    • Zefirov, Nikolay A.;
    • Radchenko, Eugene V.;
    • Palyulin, Vladimir A.;
    • Grishin, Yuri K.;
    • Vasilichin, Vladislav A.;
    • Shtil, Alexander A.;
    • Shevtsov, Pavel N.;
    • Shevtsova, Elena F.;
    • Kuznetsova, Tamara S.;
    • Kuznetsov, Sergei A.;
    • Bunev, Alexander S.;
    • Zefirova, Olga N.;
    • Milaeva, Elena R.;
    • Averina, Elena B.
    Publication type:
    Article
    12
    13
    14

    New 4‐phenylpiperazine‐carbodithioate‐N‐phenylacetamide hybrids: Synthesis, in vitro and in silico evaluations against cholinesterase and α‐glucosidase enzymes.

    Published in:
    Archiv der Pharmazie, 2022, v. 355, n. 5, p. 1, doi. 10.1002/ardp.202100313
    By:
    • Mohammadi‐Khanaposhtani, Maryam;
    • Nori, Milad;
    • Valizadeh, Yousef;
    • Javanshir, Shahrzad;
    • Dastyafteh, Navid;
    • Moaazam, Ali;
    • Hosseini, Samanesadat;
    • Larijani, Bagher;
    • Adibi, Hossein;
    • Biglar, Mahmood;
    • Hamedifar, Haleh;
    • Mahdavi, Mohammad;
    • Kamci, Hamdi;
    • Karakus, Ahmet;
    • Taslimi, Parham
    Publication type:
    Article